A clinical trial to study how safe is a lazer treatment procedure and its effects on patients with dryness of eyes.
- Conditions
- Health Condition 1: H018- Other specified inflammations of eyelid
- Registration Number
- CTRI/2022/07/044052
- Lead Sponsor
- Suhani Dhar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
1.18-year-old and above
2. Diagnosed with moderate to severe MGD according to previously reported diagnostic
criteria comprising of ocular signs and symptoms along with various tests such as
Fluorescein Tear Film Break-up Time (FTBUT) and Schirmerâ??s Test.
3. Ocular Surface Disease Index Score (ODSI) in both eyes.
4. Obstruction of MG orifices observed under slit lamp examination.
5. Presenting at least two clinical signs: redness or thickening of the lid margin,
telangiectasia, reduced or no secretions, poor quality secretions, and Meibomian gland
capping
6. Willing to complete the three treatments and follow up regularly.
1. Dermatosis or disorders of eyes and face.
2. Ocular surgery or trauma in last 3 months,
3. Active intraocular inflammation, allergy or infection
4. Eye lid structural abnormality.
5. Skin cancer or pigmented lesion in treatment zone.
6. Pregnancy and lactation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method